FR10C0012I1 - - Google Patents

Info

Publication number
FR10C0012I1
FR10C0012I1 FR10C0012C FR10C0012I1 FR 10C0012 I1 FR10C0012 I1 FR 10C0012I1 FR 10C0012 C FR10C0012 C FR 10C0012C FR 10C0012 I1 FR10C0012 I1 FR 10C0012I1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9449457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR10C0012(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of FR10C0012I1 publication Critical patent/FR10C0012I1/fr
Application granted granted Critical
Publication of FR10C0012I2 publication Critical patent/FR10C0012I2/fr
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04Dimeric indole alkaloids, e.g. vincaleucoblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
FR10C0012C 1993-07-21 2010-03-04 Active FR10C0012I2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9308948A FR2707988B1 (fr) 1993-07-21 1993-07-21 Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
PCT/FR1994/000898 WO1995003312A1 (fr) 1993-07-21 1994-07-19 Derives antimitotiques des alcaloides binaires du catharanthus roseus

Publications (2)

Publication Number Publication Date
FR10C0012I1 true FR10C0012I1 (de) 2010-04-16
FR10C0012I2 FR10C0012I2 (de) 2011-04-01

Family

ID=9449457

Family Applications (2)

Application Number Title Priority Date Filing Date
FR9308948A Expired - Lifetime FR2707988B1 (fr) 1993-07-21 1993-07-21 Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
FR10C0012C Active FR10C0012I2 (de) 1993-07-21 2010-03-04

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR9308948A Expired - Lifetime FR2707988B1 (fr) 1993-07-21 1993-07-21 Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.

Country Status (15)

Country Link
US (1) US5620985A (de)
EP (1) EP0710240B1 (de)
JP (1) JP3606872B2 (de)
AT (1) ATE146477T1 (de)
AU (1) AU693460B2 (de)
BR (1) BR1100311A (de)
CA (1) CA2167694C (de)
DE (2) DE122010000012I1 (de)
DK (1) DK0710240T3 (de)
ES (1) ES2097659T3 (de)
FR (2) FR2707988B1 (de)
GR (1) GR3022659T3 (de)
LU (1) LU91660I2 (de)
NZ (2) NZ269172A (de)
WO (1) WO1995003312A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737208A1 (fr) * 1995-07-28 1997-01-31 Pf Medicament Nouvelles fluorovindolines, precurseurs d'analogues de la vinblastine et de la vinorelbine,leurs procedes de preparation et leur utilisation comme medicament
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
FR2783522A1 (fr) * 1998-09-21 2000-03-24 Pf Medicament Composes derives d'alcaloides de vinca, leur preparation et leur application en therapeutique
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US6890558B2 (en) * 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
NZ547370A (en) 2003-12-04 2010-09-30 Amr Technology Inc Vinca derivatives
US7235564B2 (en) 2003-12-04 2007-06-26 Amr Technology, Inc. Vinorelbine derivatives
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US7422741B2 (en) 2004-03-05 2008-09-09 Vegenics Limited VEGFR-3 fusion proteins
FR2894966B1 (fr) * 2005-12-20 2008-03-14 Pierre Fabre Medicament Sa Nouvelle forme cristalline de la vinflunine
CA2642717C (en) 2006-02-17 2015-08-18 Novacea, Inc. Treatment of hyperproliferative diseases with vinca alkaloid n-oxide and analogs
CN101108859A (zh) * 2006-07-17 2008-01-23 上海恒瑞医药有限公司 长春碱类化合物、其制备方法及其在医药上的用途
US20080125451A1 (en) * 2006-09-12 2008-05-29 Amr Technology, Inc. Vinorelbine derivatives
US8039453B2 (en) * 2006-09-12 2011-10-18 Albany Molecular Research, Inc. Vinca derivatives
FR2905949B1 (fr) * 2006-09-20 2008-11-21 Pierre Fabre Medicament Sa Derives fluores de catharanthine, leur preparation et leur utilisation comme precurseurs d'alcaloides dimeres de vinca
CN101235046B (zh) * 2007-01-29 2010-09-08 中国科学院上海药物研究所 长春碱衍生物、其制备方法和用途、以及包含该衍生物的药物组合物
FR2912406B1 (fr) * 2007-02-13 2009-05-08 Pierre Fabre Medicament Sa Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine.
EP1997534A1 (de) * 2007-05-31 2008-12-03 Pierre Fabre Medicament Kombinationstherapie zur Krebsbehandlung mit Vinflunin und Trastuzumab
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr) 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
US20090076055A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched vinflunine
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
JP5793084B2 (ja) 2008-12-23 2015-10-14 ギリアド ファーマセット エルエルシー プリンヌクレオシドの合成
CA2748057C (en) 2008-12-23 2018-07-03 Pharmasset, Inc. Nucleoside phosphoramidates
BRPI0922508A8 (pt) 2008-12-23 2016-01-19 Pharmasset Inc Análogos de nucleosídeo
EP2547359B1 (de) 2010-03-15 2016-03-09 The Board of Trustees of the University of Illionis Hemmer von interaktionen, die beta-integrin-g protein-alpha-untereinheit binden
CN102858790A (zh) 2010-03-31 2013-01-02 吉利德制药有限责任公司 核苷氨基磷酸酯
EP2655401B1 (de) 2010-12-20 2016-03-09 The Regents of the University of Michigan Hemmer der bindeinteraktion des epidermalen wachstumsfaktor-rezeptor-wärmeschock-proteins 90
CN103788117A (zh) * 2012-10-30 2014-05-14 何小解 一种脱水长春碱、长春瑞滨及长春氟宁连续化合成工艺
HU230462B1 (hu) 2013-05-30 2016-07-28 Richter Gedeon Nyrt. Új bisz-indol alkaloidok mint rákellenes gyógyszerek
CN106061948A (zh) 2014-01-15 2016-10-26 国家科学研究中心 水溶性的4‑氮杂鬼臼毒素类似物
US10308719B2 (en) 2015-01-26 2019-06-04 The University Of Chicago IL13Rα2 binding agents and use thereof in cancer treatment
WO2016123143A1 (en) 2015-01-26 2016-08-04 The University Of Chicago CAR T-CELLS RECOGNIZING CANCER-SPECIFIC IL 13Rα2
WO2017152972A1 (en) * 2016-03-09 2017-09-14 Synbias Pharma Ag Vinorelbine monotartrate and its pharmaceutical use
WO2018007554A1 (en) 2016-07-06 2018-01-11 Pierre Fabre Medicament Vinflunine and pd1 and/or pdl1 inhibitor as pharmaceutical combination
TW201912173A (zh) 2017-08-07 2019-04-01 美商安進公司 三陰性乳癌或結腸直腸癌伴隨肝轉移之治療
WO2020191342A1 (en) 2019-03-20 2020-09-24 The Regents Of The University Of California Claudin-6 antibodies and drug conjugates
CA3132656A1 (en) 2019-04-30 2020-11-05 Instituto De Medicina Molecular Joao Lobo Antunes Rank pathway inhibitors in combination with cdk inhibitors
CA3140904A1 (en) 2019-06-24 2020-12-30 Amgen Inc. Inhibition of sirp-gamma for cancer treatment
FR3140369A1 (fr) 2022-10-04 2024-04-05 Universite De Poitiers Procédé de fluoration et/ou cyclisation d’un alcène ou alcyne aminé en flux continu et installation pour la mise en œuvre du procédé

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2296418B1 (de) * 1974-12-30 1978-07-21 Anvar
US4110330A (en) * 1977-05-27 1978-08-29 Eli Lilly And Company 5'-Acetonylvincristine and related compounds
US4203898A (en) * 1977-08-29 1980-05-20 Eli Lilly And Company Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids
US4307100A (en) * 1978-08-24 1981-12-22 Agence Nationale De Valorisation De La Recherche (Anvar) Nor bis-indole compounds usable as medicaments
US4320058A (en) * 1980-12-29 1982-03-16 Eli Lilly And Company 20'-Hydroxyvinblastine and related compounds
HU193772B (en) * 1985-06-12 1987-11-30 Richter Gedeon Vegyeszet Process for producing new nitro-bis-indole derivatives

Also Published As

Publication number Publication date
CA2167694C (fr) 2007-03-06
CA2167694A1 (fr) 1995-02-02
WO1995003312A1 (fr) 1995-02-02
NZ328612A (en) 2000-05-26
AU7266694A (en) 1995-02-20
ES2097659T3 (es) 1997-04-01
EP0710240A1 (de) 1996-05-08
JPH09500634A (ja) 1997-01-21
DE69401216T2 (de) 1997-07-03
BR1100311A (pt) 1999-08-31
NZ269172A (en) 1997-10-24
ATE146477T1 (de) 1997-01-15
EP0710240B1 (de) 1996-12-18
FR10C0012I2 (de) 2011-04-01
FR2707988B1 (fr) 1995-10-13
JP3606872B2 (ja) 2005-01-05
DE69401216D1 (de) 1997-01-30
US5620985A (en) 1997-04-15
AU693460B2 (en) 1998-07-02
DE122010000012I1 (de) 2010-07-08
DK0710240T3 (da) 1997-06-02
GR3022659T3 (en) 1997-05-31
FR2707988A1 (fr) 1995-01-27
LU91660I2 (fr) 2010-05-10

Similar Documents

Publication Publication Date Title
FR10C0012I2 (de)
DE9305074U1 (de)
DE9300991U1 (de)
DE9300499U1 (de)
DE9300400U1 (de)
DE9305692U1 (de)
DE9305442U1 (de)
DE9303350U1 (de)
DE9302966U1 (de)
TW276330B (de)
DE9301448U1 (de)
DE9306347U1 (de)
DE9300761U1 (de)
DE9301235U1 (de)
DE9300946U1 (de)
DE9300097U1 (de)
DE9302999U1 (de)
DE9304005U1 (de)
DE9305056U1 (de)
DE9300938U1 (de)
DE9300188U1 (de)
DE9300399U1 (de)
DE9303434U1 (de)
DE9306033U1 (de)
DE9306391U1 (de)